Safety and efficacy of Bivalirudin with Glycoprotein IIb/IIIa for high-risk percutaneous coronary intervention

AIMS: The aim of the study was to assess the safety and efficacy of Bivalirudin + Glycoprotein (Gp) IIb/IIIa inhibitor as compared to unfractionated Heparin (UFH) + Gp IIb/IIIa inhibitor in high risk patients undergoing elective percutaneous coronary intervention (PCI). The primary end point was tim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Deshpande, Niteen V., Pratiti, Rebecca, Admane, Parag, Mukherjee, Debabrata, Mardikar, Harshawardhan M.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3860907/
https://ncbi.nlm.nih.gov/pubmed/23102380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2012.07.022
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars